Norbert Gattermann

Head & Neck Surgery
Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Comparison of time to therapy initiation, therapeutic strategies and survival in patients with MDS IB1, IB2 and AML-MR using data of the duesseldorf registries.

Comparison of time to therapy initiation, therapeutic strategies and survival in patients with MDS IB1, IB2 and AML-MR using data of the duesseldorf registries.

Journal: Annals of hematology

Published: May 15, 2026

Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromes.

Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromes.

Journal: Annals of hematology

Published: February 06, 2026

High serum ferritin is associated with genetic instability in myelodysplastic neoplasms.

High serum ferritin is associated with genetic instability in myelodysplastic neoplasms.

Journal: Journal of cancer research and clinical oncology

Published: January 17, 2026

Feasibility of a virtual reality (VR)-supported mindfulness intervention for patients with cancer during chemotherapy

Feasibility of a virtual reality (VR)-supported mindfulness intervention for patients with cancer during chemotherapy

Journal: Psychotherapie, Psychosomatik, medizinische Psychologie

Published: December 15, 2025

Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.

Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry.

Journal: Annals of hematology

Published: November 10, 2025

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

Journal: Leukemia

Published: October 28, 2025

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis.

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis.

Journal: Annals of hematology

Published: May 15, 2025

Virtual Reality and Sound Intervention under Chemotherapy (ViSu): study protocol for a three-arm randomised-controlled trial.

Virtual Reality and Sound Intervention under Chemotherapy (ViSu): study protocol for a three-arm randomised-controlled trial.

Journal: BMJ open

Published: April 09, 2025

Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS).

Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS).

Journal: Annals of hematology

Published: April 02, 2025

Clinical management of CMML-State of the art.

Clinical management of CMML-State of the art.

Journal: British journal of haematology

Published: February 05, 2025

Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States.

Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States.

Journal: Blood cancer discovery

Published: January 29, 2025

Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

Journal: Journal of cancer research and clinical oncology

Published: January 18, 2025

Showing 1-12 of 122

Last Updated: 09/26/2026